Discontinuation and weight regain How often people stop the medication TRIUMPH-4 (n=445, 68 weeks, obesity with knee osteoarthritis): 18.2% on 12 mg, 12.2% on 9 mg, 4% on placebo 2 TRANSCEND-T2D-1 (n=537, 40 weeks, type 2 diabetes): 5.1% on 12 mg, 4.5% on 9 mg, 0% on placebo 3 Phase 2 (n=338, 48 weeks): 6 to 16% across doses, 1% on placebo 1 For comparison, Wegovys STEP-1 trial reported a discontinuation rate of around 7% due to side effects, and Mounjaros SURMOUNT-1 reported a similar rate
Additionally, the histology results found that 10 minutes post-injury a large hemorrhagic zone was observed over the white columns in the test subjects, but no change in the gray matter
Find out why your prior authorization was denied and work with your healthcare provider to submit an appeal
Factors Influencing Effectiveness The effectiveness of both Topiramate and Semaglutide can be influenced by several factors
In the same manner, one person might handle the side effects of Mounjaro better than those of Wegovy, or vice versa